![Pierre Kemula](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Kemula
Finansdirektör/CFO på
AGOMAB THERAPEUTICS NV
Förmögenhet: - $ per 2026-08-31
Profil
Pierre Kemula is currently Chief Financial Officer at CureVac SE since 2016 and Chief Financial Officer at AgomAb Therapeutics NV since 2024.
Formerly, Mr. Kemula was Chief Financial Officer & Managing Director at CureVac NV from 2021 to 2024, Chief Financial Officer at Pixium Vision SA from 2014 to 2017, and VP-Treasury, Financial Markets & Corporate Finance at Ipsen SA from 2013 to 2014.
Mr. Kemula completed undergraduate education at the London School of Economics & Political Science.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-18 | 0 ( -.--% ) | - $ | 2026-08-31 |
Aktiva positioner av Pierre Kemula
| Företag | Position | Start |
|---|---|---|
| AGOMAB THERAPEUTICS NV | Finansdirektör/CFO | 2024-11-01 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Finansdirektör/CFO | 2016-01-01 |
Tidigare kända positioner av Pierre Kemula
| Företag | Position | Slut |
|---|---|---|
| CUREVAC | Finansdirektör/CFO | 2024-10-31 |
| PIXIUM VISION | Finansdirektör/CFO | 2017-02-16 |
| IPSEN | Offentlig kommunikationskontakt | 2014-01-01 |
Pierre Kemulas utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
68
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pixium Vision SA
 Pixium Vision SA Medical SpecialtiesHealth Technology Operates as a bioelectronics company that develops bionic vision systems | Health Technology |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
